Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank COVID-19: reminder of the risks of chloroquine and hydroxychloroquine 29 May 2020Press releaseHumanCOVID-19Medicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 May 2020 29 May 2020NewsHumanCOVID-19BiosimilarsGeneric and hybrid medicinesMedicines New vaccine for prevention of Ebola virus disease recommended for approval in the European Union 29 May 2020Press releaseHumanMedicinesVaccines Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19 – update #3 28 May 2020Press releaseHumanClinical trialsMedicine shortagesQuality of medicines Essential work to combat the COVID-19 pandemic to continue during EMA's closure on 1 June 2020 28 May 2020NewsCorporateCOVID-19 European medicines regulatory network fully mobilised in fight against COVID-19 28 May 2020Press releaseHumanCorporateCOVID-19Medicines Prospective dialogue between developers and regulators makes for better evidence generation 27 May 2020NewsHumanScientific advice EMA commissions independent research to prepare for real-world monitoring of COVID-19 vaccines 27 May 2020Press releaseHumanCOVID-19Clinical trialsQuality of medicinesResearch and developmentVaccines EMA calls for high-quality observational research in context of COVID-19 26 May 2020Press releaseHumanCOVID-19Clinical trialsMedicinesResearch and development Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 18-20 May 2020 25 May 2020Press releaseVeterinaryMedicinesVaccines 1 … 81 82 83 84 85 Page 85 of 380 86 87 88 89 … 380
COVID-19: reminder of the risks of chloroquine and hydroxychloroquine 29 May 2020Press releaseHumanCOVID-19Medicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 May 2020 29 May 2020NewsHumanCOVID-19BiosimilarsGeneric and hybrid medicinesMedicines
New vaccine for prevention of Ebola virus disease recommended for approval in the European Union 29 May 2020Press releaseHumanMedicinesVaccines
Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19 – update #3 28 May 2020Press releaseHumanClinical trialsMedicine shortagesQuality of medicines
Essential work to combat the COVID-19 pandemic to continue during EMA's closure on 1 June 2020 28 May 2020NewsCorporateCOVID-19
European medicines regulatory network fully mobilised in fight against COVID-19 28 May 2020Press releaseHumanCorporateCOVID-19Medicines
Prospective dialogue between developers and regulators makes for better evidence generation 27 May 2020NewsHumanScientific advice
EMA commissions independent research to prepare for real-world monitoring of COVID-19 vaccines 27 May 2020Press releaseHumanCOVID-19Clinical trialsQuality of medicinesResearch and developmentVaccines
EMA calls for high-quality observational research in context of COVID-19 26 May 2020Press releaseHumanCOVID-19Clinical trialsMedicinesResearch and development
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 18-20 May 2020 25 May 2020Press releaseVeterinaryMedicinesVaccines